APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
64 hedge funds and large institutions have $85.8M invested in Aptose Biosciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+1
Holders Change %
+1.59%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
23
Reduced
20
Closed
10
Calls
$251K
Puts
$370K
Net Calls
-$119K
Net Calls Change
-$50K
Top Buyers
1 |
6CM
1
683 Capital Management
New York
|
$6.79M |
2 |
2
Morgan Stanley
New York
|
$3.24M |
3 |
3
Renaissance Technologies
New York
|
$1.58M |
4 |
SMH
4
Sanders Morris Harris
Houston,
Texas
|
$3.08M |
5 |
DS
5
DRW Securities
Chicago,
Illinois
|
$19.4M |